BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic MelanomaDennie T. Frederick, Jennifer A. Wargo, Zachary A. Cooper et al.|Clinical Cancer Research|2013Cited by 938
TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in <i>BRAF-</i> Mutant MelanomaRyan B. Corcoran, Jeffrey A. Engelman, S. Michael Rothenberg et al.|Science Translational Medicine|2013Cited by 138